Suchergebnisse - "Hsu, Ann"

PubPharm (20)

1

Erythroid-specific inactivation of Slc12a6/Kcc3 by EpoR promoter-driven Cre expression reduces K-Cl cotransport activity in mouse erythrocytes

enthalten in: Physiological reports | 2022

von Shmukler, B. | Rivera, A. | Nishimura, K. | +6

2

Variation of picture angles and its effect on the Concealed Information Test

enthalten in: Cognitive research: principles and implications | 2020

von Hsu, A. | Lo, Y. | Ke, S. | +2

3

Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia

enthalten in: Blood cells, molecules & diseases | 2020

von Shmukler, B. | Rivera, A. | Bhargava, P. | +11

4

Clinical Pharmacokinetics of IPX066 : Evaluation of Dose Proportionality and Effect of Food in Healthy Volunteers

enthalten in: Clinical neuropharmacology | 2016

von Yao, H. | Hsu, A. | Gupta, S. | +1

5

Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease : A 9-Month Open-Label Extension Trial

enthalten in: CNS drugs | 2015

von Waters, C. | Nausieda, P. | Dzyak, L. | +8

6

Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease : Experience in Clinical Trials

enthalten in: Journal of Parkinson's disease | 2015

von Nausieda, P. | Hsu, A. | Elmer, L. | +8

7

Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients

enthalten in: Parkinsonism & related disorders | 2014

von Stocchi, F. | Hsu, A. | Khanna, S. | +7

8

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

enthalten in: Parkinsonism & related disorders | 2014

von Pahwa, R. | Lyons, K. | Hauser, R. | +64

9

Population pharmacodynamics of IPX066 : an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease

enthalten in: Journal of clinical pharmacology | 2013

von Mao, Z. | Hsu, A. | Gupta, S. | +1

10

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations : a phase 3 randomised, double-blind trial

enthalten in: The Lancet. Neurology | 2013

von Hauser, R. | Hsu, A. | Kell, S. | +7

CommentIn: Lancet Neurol. 2013 Apr;12(4):325-6. - PMID 23485609